Streetbeat News

Revenues

RCM

R1 RCM has announced that it is on track to achieve its guidance for 2023, with expected revenue of $2.255 billion to $2.275 billion.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:27 am

CRTO

Criteo, a global technology company, has projected a revenue growth of 9% to 10% for the fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:27 am

VITL

Vital Farms has reaffirmed its net revenue guidance for FY23 at over $465M, against an estimate of $468.54M. The company's management expects to generate annual net revenue of more than $1 billion by the end of fiscal year 2027. They also anticipate a gross margin of at least 35% of net revenue and an Adjusted EBITDA Margin in the range of 12% to 14% by FY27.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:24 am

BAX

Baxter International Inc. anticipates sales growth from continuing operations of 1%-2% on a reported basis and approximately 2% on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:22 am

ZTS

Zoetis has revised its FY23 revenue guidance from $8.500B - $8.650B to $8.475B - $8.550B, which is slightly below the estimated $8.59B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:20 am

TAP

Molson Coors has reaffirmed its revenue growth forecast for FY23, expecting high single-digit growth compared to 2022.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:14 am

PGY

Pagaya Technologies Ltd has raised its FY23 outlook for Network Volume, Total Revenue and Other Income, and Adjusted EBITDA. The company now expects its FY23 revenue to be between $800M and $825M, up from the previous estimate of $775M-$825M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:14 am

CCLD

CareCloud has reiterated its revenue guidance for 2023, which is expected to be between $120M and $133M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:13 am

BCRX

BioCryst Pharmaceuticals has projected a minimum of $320 million in FY23 revenue from Orladeyo and expects to reach $1 billion in peak Orladeyo revenue.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:12 am

LNTH

Lantheus has increased the lower end of its FY23 revenue guidance from $1.245B to $1.255B, while the upper end remains at $1.27B. The new range is slightly below the estimated $1.26B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:12 am